# | Title | Journal | Year | Citations |
---|
1 | Inflammation, Growth Factors, and Pulmonary Vascular Remodeling | Journal of the American College of Cardiology | 2009 | 605 |
2 | EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis | Annals of the Rheumatic Diseases | 2007 | 524 |
3 | Mapping and predicting mortality from systemic sclerosis | Annals of the Rheumatic Diseases | 2017 | 410 |
4 | Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data | BMJ, The | 2020 | 355 |
5 | Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome | Annals of the Rheumatic Diseases | 2007 | 261 |
6 | Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis | Blood | 2008 | 252 |
7 | Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome | JAMA - Journal of the American Medical Association | 2014 | 241 |
8 | Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies | Nature Medicine | 2022 | 235 |
9 | Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI) | Annals of the Rheumatic Diseases | 2016 | 225 |
10 | Churg–Strauss syndrome | Current Opinion in Rheumatology | 2007 | 199 |
11 | IgA vasculitis (Henoch–Shönlein purpura) in adults: Diagnostic and therapeutic aspects | Autoimmunity Reviews | 2015 | 187 |
12 | High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients | Annals of the Rheumatic Diseases | 2009 | 184 |
13 | Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis | Annals of the Rheumatic Diseases | 2013 | 183 |
14 | Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients | PLoS ONE | 2017 | 174 |
15 | Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients* | British Journal of Dermatology | 2022 | 174 |
16 | Population‐based prevalence study of Behçet's disease: Differences by ethnic origin and low variation by age at immigration | Arthritis and Rheumatism | 2008 | 170 |
17 | Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis | Kidney International | 2006 | 144 |
18 | Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) | Autoimmunity Reviews | 2017 | 140 |
19 | Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides | Annals of the Rheumatic Diseases | 2018 | 139 |
20 | Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients | Annals of the Rheumatic Diseases | 2009 | 131 |
21 | Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester disease | Blood | 2010 | 129 |
22 | Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis | Annals of the Rheumatic Diseases | 2010 | 125 |
23 | Granulomatous Disease in CVID: Retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 Patients | Journal of Clinical Immunology | 2013 | 125 |
24 | Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? | Annals of the Rheumatic Diseases | 2006 | 122 |
25 | Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome | Autoimmunity Reviews | 2017 | 120 |
26 | Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale | Annals of the Rheumatic Diseases | 2007 | 119 |
27 | The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study | Thorax | 2008 | 119 |
28 | Characteristics and Management of IgA Vasculitis (Henoch‐Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey | Arthritis and Rheumatology | 2017 | 117 |
29 | Adding Azathioprine to Remission‐Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors | Arthritis and Rheumatology | 2017 | 117 |
30 | Diversification of human plasmacytoid predendritic cells in response to a single stimulus | Nature Immunology | 2018 | 106 |
31 | Churg–Strauss syndrome: evidence for disease subtypes? | Current Opinion in Rheumatology | 2010 | 103 |
32 | Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers | Arthritis Care and Research | 2011 | 94 |
33 | A descriptive and prognostic study of systemic sclerosis-associated myopathies | Annals of the Rheumatic Diseases | 2009 | 87 |
34 | Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry | British Journal of Haematology | 2022 | 85 |
35 | Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP) | Neuromuscular Disorders | 2006 | 84 |
36 | Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients | Annals of the Rheumatic Diseases | 2007 | 81 |
37 | 2020 international consensus on ANCA testing beyond systemic vasculitis | Autoimmunity Reviews | 2020 | 79 |
38 | A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis | American Journal of Human Genetics | 2017 | 78 |
39 | Suppression of Ectopic Adrenocorticotropin Secretion by the Long-Acting Somatostatin Analog Octreotide* | Journal of Clinical Endocrinology and Metabolism | 1989 | 77 |
40 | Systemic Sclerosis‐Associated Myopathy | Annals of the New York Academy of Sciences | 2007 | 77 |
41 | Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature | Journal of Autoimmunity | 2015 | 76 |
42 | Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis | Journal of Rheumatology | 2012 | 75 |
43 | Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry | Annals of the Rheumatic Diseases | 2016 | 72 |
44 | Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia | Autoimmunity Reviews | 2005 | 71 |
45 | Peripheral neuropathy in systemic vasculitides | Current Opinion in Rheumatology | 2005 | 70 |
46 | Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients | Autoimmunity Reviews | 2014 | 69 |
47 | Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy | Aids | 2000 | 68 |
48 | Recommendations for the care of oral involvement in patients with systemic sclerosis | Arthritis Care and Research | 2011 | 68 |
49 | Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remission | Rheumatology | 2010 | 66 |
50 | Myopathies related to systemic sclerosis: a case–control study of associated clinical and immunological features | Scandinavian Journal of Rheumatology | 2010 | 64 |